Top Tweets for #TROPICS2
Excellent #BreastCancer session Best of #ASCO23 #Lebanon with H Azim A Kandil H AbdelRazeq M Al-Foheidi @JavierCortesMD D Cameron A Awada #Natalee #monarchE #SONIAtrial #TROPICS2 @OncoAlert
2. #Sacituzumab govitecan (Trop-2/TOP1 ADC) is already approved for TNBC and bladder cancer.
#TROPiCS2 Ph3, HR+/HER2- aBC after ET/CDK4/6i, & ≥2 L chemo:
- Met PFS (HR 0.66) & OS (0.79) endpoint
- Pending approval
- Benefit across all TROP-2 expressions
#SABCSUpdate
1. #SABCS22 updates w/ @DrSGraff from @BrownUCancer on HR+ #breastcancer:
- #TAM01 "BabyTam"
- #EMERALD: Elacestrant
- #CAPItello291: Capivasertib
- #TROPiCS2: Sacituzumab Govitecan
https://t.co/c3OFI7jb6N
#bcsm #SABCSUpdate
@OncoAlert @SoMeCME @SABCSSanAntonio
1/ #SABCSUpdate
📣 #OncTwitter: Clinically relevant updates on CDK4/6 inhibitors in HR+/HER2- advanced #breastcancer w/ @DrSGraff & @OncBrothers!
Supported by educational grants from Gilead & Lilly.
CME ℹ️ https://t.co/AxyPrqAEIi
📊 What is your specialty❓
2. #TROPICS2 OS Update, Ph3, N=543, HR+ve mBC, #Sacituzumab vs TPC by @hoperugo in heavily treated patient population
- Improved mOS: 14.4mos vs 11.2mos (HR: 0.79)
- Prolonged mDOR
- No new safety signal
3/6
9. #TROPICS2 at #ASCO22 for HR+ve mBC, #Sacituzumab govitecan vs TPC by
@hoperugo
- Ph3, N=543,
- Improved mPFS (5.5 mos Vs. 4 mos) with Saci
- Immature OS data (trend towards OS)
- 74% Vs 60% ≥ Grade 3 AEs with Sacituzumab
5. #PALOMA3 Updated OS
6. #AGILE - #Ivosidenib + Aza
approved - 1L IDH-1 mutated AML
7. #CM648 - Nivo and Ipi approved - 1L adv/met esophageal squam cell CA
8. #DYNAMIC - ctDNA guided Rx in CRC
9. #TROPiCS2 Sacituzumab for HR+ve mBC
#bcsm #leusm #GISM #MedTwitter
Breast Ca #ASCO22 highlights w/ @stolaney1. For & by the community oncologists!
#PALOMA2
#TROPiCS2 by @hoperugo
#DB04
Full Interview
- https://t.co/UFsq4enw50
- https://t.co/evp06TDvBq
Appreciate feedback
#OncTwitter #BCSM #MedTwitter
@DrSGraff @Dr_RShatsky @ErikaHamilton9
3. #TROPICS2, Ph3, N=543, HR+ve mBC, #Sacituzumab govitecan vs TPC by @hoperugo
- Improved mPFS (5.5 mos Vs. 4 mos) with Saci
- Immature OS data (trend towards OS)
- 74% Vs 60% ≥ Grade 3 AEs with Sacituzumab
4/5
Day 2 #ASCO22 Highlights
#CommunityOncology perspective
1. #DestinyBreast03 in mBC by @ErikaHamilton9
2. #PALOMA 2 update in mBC
3. #TROPICS2 in mBC by @hoperugo
4. #DYNAMIC: ctDNA guiding adjuvant Rx in CRC
#MedEd #MedTwitter @OncoAlert @ASCO
1/5
Last Seen Hashtags on Sotwe
elmirrey
Seen from United States
dulkadın
Seen from Turkey
nolimit()******** +filter:native_video
Seen from United States
rr34 thighjob
Seen from Singapore
MaaIntiBangaaram
Seen from Germany
elaziggay
Seen from Turkey
ünlüfrikik
นัดเย็ดสีคิ้ว
Seen from Thailand
grandpa
Seen from United States
nolimit() +filter:media() -filter:images
Seen from Brazil
Most Popular Users
Elon Musk 
@elonmusk
240.3M followers
Barack Obama
@barackobama
119.3M followers
Donald J. Trump
@realdonaldtrump
111.6M followers
Cristiano Ronaldo
@cristiano
109.9M followers
Narendra Modi
@narendramodi
106.9M followers
Rihanna
@rihanna
97.5M followers
NASA
@nasa
92.1M followers
Justin Bieber
@justinbieber
90.8M followers
KATY PERRY
@katyperry
87.3M followers
Taylor Swift
@taylorswift13
81.1M followers
Lady Gaga
@ladygaga
72.7M followers
Kim Kardashian
@kimkardashian
69.6M followers
Virat Kohli
@imvkohli
69.3M followers
YouTube
@youtube
68.6M followers
Bill Gates
@billgates
63.7M followers
The Ellen Show
@theellenshow
62.5M followers
Neymar Jr
@neymarjr
62M followers
CNN
@cnn
61.9M followers
X
@x
60.9M followers
Selena Gomez
@selenagomez
60.4M followers